It is truly inspiring and rewarding to be a part of a client’s successful story for the diverse and dynamic industry of healthcare.
Jens provides mergers and acquisitions (M&A) advisory to clients across the entire healthcare spectrum. He has experience in complex sell-side and buy-side transactions, as well as capital advisory engagements, and has completed various private and public transactions with international corporations, financial sponsors and owner-managed businesses.
Jens has a deep knowledge of the healthcare industry, having worked with companies in the hospital, rehab, physician practices, nursing and home care sectors. He has also gained experience in healthcare software, medical technology and equipment manufacturing sectors.
Prior to joining Lincoln, Jens worked as a Director and Vice President in the healthcare investment banking practice at Raymond James. Previously, Jens worked in Citigroup’s investment banking department and in Berenberg’s corporate finance practice.
Jens earned a Bachelor of Science in business administration from the Goethe University Frankfurt.
Recent Transactions in Healthcare
Lincoln International served as the exclusive financial advisor and debt arranger to OrthoFi on its acquisition of OrthoBanc
Lincoln International is pleased to have advised AnGes, Inc. on its acquisition of EmendoBio, Inc., a leader in next-generation novel nuclease discovery and gene editing technologies, at a valuation of $250 million
Lincoln International is pleased to announce that Strive Medical has been acquired by NMS Capital
Lincoln International is pleased to announce that KIMS Property Company Limited, a portfolio company of Magnetar Financial (UK) LLP, has extended its senior facilities
Lincoln International advises New Harbor Capital on the sale of Wedgewood Pharmacy to Partners Group
Lincoln International advised The FSB Companies LLC on the sale of Pinnacle Medical Solutions LLC to AdaptHealth Corp.
Lincoln International advised The Vet Connection on its sale to Pets at Home Group PLC (LSE:PETS)